Exercise tolerance in systemic sclerosis patients without pulmonary impairment: Correlation with clinical variables

Clinical and Experimental Rheumatology

Volumn 32, Issue , 2014, Pages 103-108

  Rosato, Edoardo ^a   Romaniello, Antonella ^a   Magrì, Damiano ^a   Bonini, Matteo ^b   Sardo, Liborio ^a   Gigante, Antonietta ^a   Quarta, Silvia ^a   Digiulio, Maria Anna ^a   Viola, Giovanna ^a   Di Paolo, Marcello ^b   Jacoangeli, Francesca ^a   Baiocchi, Pia ^b   Salsano, Felice ^a   Palange, Paolo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Capillaroscopy; Cardiopulmonary exercise test; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CAPILLAROSCOPY; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; FINGER ULCER; HUMAN; LUNG FUNCTION; LUNG MINUTE VOLUME; LUNG VENTILATION; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY VASCULAR DISEASE; SYSTEMIC SCLEROSIS; AGED; CASE CONTROL STUDY; COMPLICATION; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HAND DERMATOSES; HYPERTENSION, PULMONARY; LUNG DISEASES; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN ULCER; VASCULAR DISEASES; VITAL CAPACITY; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HAND DERMATOSES; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PULMONARY VENTILATION; SCLERODERMA, SYSTEMIC; SKIN ULCER; VASCULAR DISEASES; VITAL CAPACITY; YOUNG ADULT;

EID: 84969900668     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. CAMPBELL PM, LeROY EC: Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975; 4: 351-68
2. ROSATO E, GIGANTE A, BARBANO B et al.: In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage. Microvasc Res 2011; 82: 410-5
3. LEE P, LANGEVITZ P, BUSKLIA D: Mortality in systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90
4. MUKERJEE D, St GEORGE D, COLEIRO B et al.: Prevalence and outcome in systemic sclerosis associated pulmonary hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93
5. SUDDUTH CD, STRANGE C, COOK WR et al.: Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993; 95: 413-8
6. BLOM-BÜLOW B, JONSON B, BAUER K: Factors limiting exercise performance in progressive systemic sclerosis. Semin Arthritis Rheum 1983; 2: 174-81
7. MORELLI S, FERRANTE L, SGRECCIA A et al.: Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 2000; 29: 236-42
8. SCHWAIBLMAIR M, BEHR J, FRUHMANN G: Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1520-5
9. SCHURAWITZKI H, STIGLBAUER R, GRANINGER W et al.: Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990; 176: 755-59
10. DUMITRESCU D, OUDIZ RJ, KARPOUZAS G et al.: Developing Pulmonary Vasculopathy in Systemic Sclerosis, Detected with Non-Invasive Cardiopulmonary Exercise Testing. PLoS One 2010; 5: e14293
11. van den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 2013; 65: 2737-47
12. LeROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998; 15: 202-5
13. MILLER MR, KRAPO R, HANKINSON J et al.: General considerations for lung function testing. Eur Respir J 2005; 26: 153-61
14. ABBOUD RT, SANSORES R: ATS recommendations for DLCO. Am J Respir Crit Care Med 1996; 154: 263
15. AGOSTONI P, BIANCHI M, MORASCHI A et al.: Work-rate affects cardiopulmonary exercise test results in heart failure. Eur J Heart Fail 2005; 7: 498-504
16. BUSSOTTI M, MAGRÌ D, PREVITALI E et al.: End-tidal pressure of CO2 and exercise performance in healthy subjects. Eur J Appl Physiol 2008; 103: 727-32
17. AGOSTONI P, VALENTINI M, MAGRí D et al.: Disappearance of isocapnic buffering period during increasing work rate exercise at high altitude. Eur J Cardiovasc Prev Rehabil 2008; 15: 354-8
18. ERS TASK FORCE, PALANGE P, WARD SA et al.: Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185-209
19. KAZEROONI EA, MARTINEZ FJ, FLINT A et al.: Thin-section CT obtained at 10-mm increments versus limited three-level thinsection CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997; 169: 977-83
20. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT) et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-63
21. CUTOLO M, SULLI A, SECCHI ME, PAOLINO S, PIZZORNI C: Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 2006; 45 (Suppl. 4): 43-6
22. CLEMENTS P, LACHENBRUCH P, SEIBOLD J et al.: Inter-and intraobserver variability of the total thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5
23. VALENTINI G, Della ROSSA A, BOMBARDIERI S et al.: European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001; 60: 592-8
24. MEDSGER TA Jr, SILMAN AJ, STEEN VD et al.: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159-67
25. MATUCCI-CERINIC M, KAHALEH B, WIGLEY FM: Systemic sclerosis (scleroderma, SSc) is a vascular disease. Arthritis Rheum 2013; 65: 1953-62
26. SCHWAIBLMAIR M, BEHR J, FRUHMANN G: Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1520-5
27. MAGRÌ D, AGOSTONI P, CAUTI FM et al.: Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study. Intern Emerg Med 2014; 9: 293-302
28. AGOSTONI P, CORRà U, CATTADORI G et al.: Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710-8
29. MAGRÌ D, BRIOSCHI M, BANFI C et al.: Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure. Circ Heart Fail 2009; 2: 175-80
30. AGOSTONI P, CORRà U, CATTADORI G et al.: Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710-8
31. POGGIO R, ARAZI HC, GIORGI M, MIRIUKA SG: Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. Am Heart J 2010; 160: 1004-14
32. MOORE B, BRUBAKER PH, STEWART KP, KITZMAN DW: VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. J Card Fail 2007; 13: 259-62
33. HARGARDóTTIR H, van HELVOORT HA, VONK MC, van den HOOGEN FH, DEKHUIJZEN PN, HEIJDRA YF: Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress. Scand J Rheumatol 2010; 39: 63-70
34. WALKEY AJ, IEONG M, ALIKHAN M, FARBER HW: Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis. J Rheumatol 2010; 37: 1871-7
35. CHIGHIZOLA C, MERONI PL, SCHREIBER BE, COGHLAN JG, DENTON CP, ONG VH: Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients. Clin Exp Rheumatol 2012; 30 (Suppl. 71): S81-5
36. HINCHCLIFF M, DESAI CS, VARGA J, SHAH SJ: Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol 2012; 30 (Suppl. 71): S30-7
37. CUOMO G, SANTORIELLO C, POLVERINO F, RUOCCO L, VALENTINI G, POLVERINO M: Impaired exercise performance in systemic sclerosis and its clinical correlations. Scand J Rheumatol 2010; 39: 330-5
38. IUDICI M, CODULLO V, GIUGGIOLI D et al.: Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. Clin Exp Rheumatol 2013; 31(Suppl. 76): S31-6
39. ROSATO E, GIGANTE A, BARBANO B et al.: Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis. Semin Arthritis Rheum 2012; 41: 815-21
40. HOFSTEE HM, VONK NOORDEGRAAF A, VOSKUYL AE et al.: Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2009; 68: 191-5
41. ROSATO E, BARBANO B, GIGANTE A et al.: Erectile dysfunction, endothelium dysfunction, and microvascular damage in patients with systemic sclerosis. J Sex Med 2013; 10: 1380-8